Coleus Forskohlii
•Last Updated: November 17 2022
Coleus forskohlii is an herb used in traditional medicine that may boost testosterone and induce fat loss, particularly in men.
Coleus Forskohlii is most often used for
Last Updated: November 17 2022
Coleus forskohlii is an herb historically used in Ayurveda (Ayurvedic medicine).
Today, Coleus forskohlii is used as a fat burning supplement.
The main bioactive ingredient in Coleus forskohlii is called forskolin. Through forskolin, Coleus forskohlii supplementation may increase testosterone, and protect against cancer and inflammation. Further research is needed to confirm these effects, since forskolin is most often used as a research tool in vitro, or outside the body, like in a test tube or petri dish. Forskolin may act differently inside the body.
Forskolin increases cellular levels of a molecule called cyclic adenosine monophosphate (cAMP). Elevated cAMP levels are associated with increased rates of fat loss, and can improve the effects of other fat burning compounds.
Forskolin is still being researched for its effects on testosterone and fat loss, but preliminary evidence is promising.
Note that Coleus Forskohlii is also known as:
- Forskolin
- Coleonol
- 7-Beta-acetoxy-8 13-epoxy-1-alpha 6-Beta 9-alpha-trihydroxy-labd-14-en-11-one
To supplement Coleus forskohlii, take 250 mg of a supplement that contains 10% forskolin, twice a day, for a 500 mg total daily dose.
Further research is needed to determine the optimal Coleus forskohlii dose.
3.^Rosmarinic acid, scutellarein 4′-methyl ether 7-O-glucuronide and (16S)-coleon E are the main compounds responsible for the antiacetylcholinesterase and antioxidant activity in herbal tea of Plectranthus barbatus (“falso boldo”)
4.^Wang YQ, Ma JP, Pan SL, Hou AJ, Huang JMStudies on the chemical constituents of Coleus forskohliiZhong Yao Cai.(2009 Sep)
5.^Bodiwala HS, Sabde S, Mitra D, Bhutani KK, Singh IPAnti-HIV diterpenes from Coleus forskohliiNat Prod Commun.(2009 Sep)
6.^Yang QR, Wu HZ, Wang XM, Zou GA, Liu YWThree new diterpenoids from Coleus forskohlii BriqJ Asian Nat Prod Res.(2006 Jun)
8.^Alasbahi RH, Melzig MFForskolin and derivatives as tools for studying the role of cAMPPharmazie.(2012 Jan)
9.^Shan Y, Xu L, Lu Y, Wang X, Zheng Q, Kong L, Niwa MDiterpenes from Coleus forskohlii (WILLD.) BRIQ. (Labiatae)Chem Pharm Bull (Tokyo).(2008 Jan)
10.^Shan Y, Wang X, Zhou X, Kong L, Niwa MTwo minor diterpene glycosides and an eudesman sesquiterpene from Coleus forskohliiChem Pharm Bull (Tokyo).(2007 Mar)
11.^Falé PL, Madeira PJ, Florêncio MH, Ascensão L, Serralheiro MLFunction of Plectranthus barbatus herbal tea as neuronal acetylcholinesterase inhibitorFood Funct.(2011 Feb)
12.^Antiacetylcholinesterase and antioxidant activities of Plectranthus barbatus tea, after in vitro gastrointestinal metabolism
13.^Xu LL, Lu J, Li WJ, Kong LYStudies on the chemical constituents in root of Coleus forskohliiZhongguo Zhong Yao Za Zhi.(2005 Nov)
14.^Burns TW, Langley PE, Terry BE, Bylund DB, Forte LR JrComparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytesLife Sci.(1987 Jan 12)
16.^Iwatsubo K, Tsunematsu T, Ishikawa YIsoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapyExpert Opin Ther Targets.(2003 Jun)
17.^Hanoune J, Defer NRegulation and role of adenylyl cyclase isoformsAnnu Rev Pharmacol Toxicol.(2001)
18.^Litosch I, Hudson TH, Mills I, Li SY, Fain JNForskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytesMol Pharmacol.(1982 Jul)
19.^Burns TW, Langley PE, Terry BE, Bylund DB, Forte LRAlpha-2 adrenergic activation inhibits forskolin-stimulated adenylate cyclase activity and lipolysis in human adipocytesLife Sci.(1982 Aug 23)
20.^Costford SR, Bajpeyi S, Pasarica M, Albarado DC, Thomas SC, Xie H, Church TS, Jubrias SA, Conley KE, Smith SRSkeletal muscle NAMPT is induced by exercise in humansAm J Physiol Endocrinol Metab.(2010 Jan)
21.^Dubey MP, Srimal RC, Nityanand S, Dhawan BNPharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohliiJ Ethnopharmacol.(1981 Jan)
22.^Liu ZJ, Jiang DB, Tian LL, Yin JJ, Huang JM, Weng WYIntestinal Permeability of Forskolin by In Situ Single Pass Perfusion in RatsPlanta Med.(2012 Mar 12)
23.^Mante S1, Minneman KPCaffeine inhibits forskolin-stimulated cyclic AMP accumulation in rat brainEur J Pharmacol.(1990 Jan 10)
24.^Mante S1, Minneman KPIs adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brainMol Pharmacol.(1990 Nov)
25.^DeLapp NW1, Eckols KForskolin stimulation of cyclic AMP accumulation in rat brain cortex slices is markedly enhanced by endogenous adenosineJ Neurochem.(1992 Jan)
26.^Fredholm BB, Jonzon B, Lindström KEffect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slicesNaunyn Schmiedebergs Arch Pharmacol.(1986 Feb)
27.^Alexander SP1, Losinski A, Kendall DA, Hill SJA comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aortaBr J Pharmacol.(1994 Jan)
28.^Alexander SP1, Curtis AR, Kendall DA, Hill SJA1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortexBr J Pharmacol.(1994 Dec)
29.^Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C, Smith P, Melton C, Cowan P, Greenwood M, Earnest C, Almada A, Milnor P, Magrans T, Bowden R, Ounpraseuth S, Thomas A, Kreider RBEffects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight womenJ Int Soc Sports Nutr.(2005 Dec 9)
30.^Godard MP, Johnson BA, Richmond SRBody composition and hormonal adaptations associated with forskolin consumption in overweight and obese menObes Res.(2005 Aug)
31.^Jagtap M, Chandola HM, Ravishankar BClinical efficacy of Coleus forskohlii (Willd.) Briq. (Makandi) in hypertension of geriatric populationAyu.(2011 Jan)
32.^Martin LF, Klim CM, Vannucci SJ, Dixon LB, Landis JR, LaNoue KFAlterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humansSurgery.(1990 Aug)
34.^Filippa N, Sable CL, Filloux C, Hemmings B, Van Obberghen EMechanism of protein kinase B activation by cyclic AMP-dependent protein kinaseMol Cell Biol.(1999 Jul)
36.^Duarte T, Menezes-Rodrigues FS, Godinho ROContribution of the extracellular cyclic AMP- adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscleJ Pharmacol Exp Ther.(2012 Mar 21)
38.^A novel role for β-adrenoceptor signalling in skeletal muscle growth, development and regeneration
39.^Richmond SR, Touchberry CD, Gallagher PMForskolin attenuates the action of insulin on the Akt-mTOR pathway in human skeletal muscleAppl Physiol Nutr Metab.(2009 Oct)
40.^Niu W, Bilan PJ, Hayashi M, Da Y, Yao ZInsulin sensitivity and inhibition by forskolin, dipyridamole and pentobarbital of glucose transport in three L6 muscle cell linesSci China C Life Sci.(2007 Dec)
41.^Flores-Riveros JR, Kaestner KH, Thompson KS, Lane MDCyclic AMP-induced transcriptional repression of the insulin-responsive glucose transporter (GLUT4) gene: identification of a promoter region required for down-regulation of transcriptionBiochem Biophys Res Commun.(1993 Aug 16)
42.^Cooke DW, Lane MDTranscription factor NF1 mediates repression of the GLUT4 promoter by cyclic-AMPBiochem Biophys Res Commun.(1999 Jul 14)
43.^Viñals F, Ferré J, Fandos C, Santalucia T, Testar X, Palacín M, Zorzano ACyclic adenosine 3',5'-monophosphate regulates GLUT4 and GLUT1 glucose transporter expression and stimulates transcriptional activity of the GLUT1 promoter in muscle cellsEndocrinology.(1997 Jun)
44.^Sparks LM, Moro C, Ukropcova B, Bajpeyi S, Civitarese AE, Hulver MW, Thoresen GH, Rustan AC, Smith SRRemodeling lipid metabolism and improving insulin responsiveness in human primary myotubesPLoS One.(2011)
45.^Baar KInvolvement of PPAR gamma co-activator-1, nuclear respiratory factors 1 and 2, and PPAR alpha in the adaptive response to endurance exerciseProc Nutr Soc.(2004 May)
46.^Hood DAInvited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscleJ Appl Physiol.(2001 Mar)
47.^Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JOAdaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1FASEB J.(2002 Dec)
48.^Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GWMyonectin (CTRP15), a Novel Myokine That Links Skeletal Muscle to Systemic Lipid HomeostasisJ Biol Chem.(2012 Apr 6)
49.^Mulhall JP, Daller M, Traish AM, Gupta S, Park K, Salimpour P, Payton TR, Krane RJ, Goldstein IIntracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapyJ Urol.(1997 Nov)
51.^Caprioli J, Sears MForskolin lowers intraocular pressure in rabbits, monkeys, and manLancet.(1983 Apr 30)
52.^Burstein NL, Sears ML, Mead AAqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activatorExp Eye Res.(1984 Dec)
53.^Head KANatural therapies for ocular disorders, part two: cataracts and glaucomaAltern Med Rev.(2001 Apr)
54.^Goldberg JL1, Espinosa JS, Xu Y, Davidson N, Kovacs GT, Barres BARetinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activityNeuron.(2002 Feb 28)
55.^Meyer-Franke A1, Kaplan MR, Pfrieger FW, Barres BACharacterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in cultureNeuron.(1995 Oct)
56.^Nakazawa T1, Tamai M, Mori NBrain-derived neurotrophic factor prevents axotomized retinal ganglion cell death through MAPK and PI3K signaling pathwaysInvest Ophthalmol Vis Sci.(2002 Oct)
57.^Chen H1, Weber AJBrain-derived neurotrophic factor reduces TrkB protein and mRNA in the normal retina and following optic nerve crush in adult ratsBrain Res.(2004 Jun 11)
58.^Pernet V1, Di Polo ASynergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivoBrain.(2006 Apr)
59.^Pescosolido N, Librando AOral administration of an association of forskolin, rutin and vitamins B1 and B2 potentiates the hypotonising effects of pharmacological treatments in POAG patientsClin Ter.(2010)
60.^Oral Administration of Forskolin and Rutin Contributes to Reduce Intraocular Pressure and Improve PERG (Pattern Electroretinogram) Amplitude in Glaucomatous Patients
61.^Vetrugno M1, Uva MG, Russo V, Iester M, Ciancaglini M, Brusini P, Centofanti M, Rossetti LMOral administration of forskolin and rutin contributes to intraocular pressure control in primary open angle glaucoma patients under maximum tolerated medical therapyJ Ocul Pharmacol Ther.(2012 Oct)
62.^Virgona N, Yokotani K, Yamazaki Y, Shimura F, Chiba T, Taki Y, Yamada S, Shinozuka K, Murata M, Umegaki KColeus forskohlii extract induces hepatic cytochrome P450 enzymes in miceFood Chem Toxicol.(2012 Mar)
63.^Ding X, Staudinger JLInduction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathwayJ Pharmacol Exp Ther.(2005 Feb)
64.^Valenti S, Guido R, Giusti M, Giordano GIn vitro acute and prolonged effects of melatonin on purified rat Leydig cell steroidogenesis and adenosine 3',5'-monophosphate productionEndocrinology.(1995 Dec)
66.^Payne AH, Hales DBOverview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormonesEndocr Rev.(2004 Dec)
67.^Hsu CC, Tsai SJ, Huang YL, Huang BMRegulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesisFEBS Lett.(2003 May 22)
68.^Hermansen KForskolin, an activator of adenylate cyclase, stimulates pancreatic insulin, glucagon, and somatostatin release in the dog: studies in vitroEndocrinology.(1985 Jun)
69.^De Vries GW, Amdahl LD, Lowe N, Wheeler LAEffect of forskolin on beta-adrenergic hyporesponsiveness in skinSkin Pharmacol.(1988)
70.^Harper JFDesensitization in rat parotid to beta-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activityJ Cyclic Nucleotide Protein Phosphor Res.(1986)
71.^Forskolin Potentiates Isoprenaline-Induced Glycerol Output and Local Blood Flow in Human Adipose Tissue in vivo
72.^Lafontan M, Langin DLipolysis and lipid mobilization in human adipose tissueProg Lipid Res.(2009 Sep)
73.^Wellman GC, Santana LF, Bonev AD, Nelson MTRole of phospholamban in the modulation of arterial Ca(2+) sparks and Ca(2+)-activated K(+) channels by cAMPAm J Physiol Cell Physiol.(2001 Sep)
74.^Jeffries O, McGahon MK, Bankhead P, Lozano MM, Scholfield CN, Curtis TM, McGeown JGcAMP/PKA-dependent increases in Ca Sparks, oscillations and SR Ca stores in retinal arteriolar myocytes after exposure to vasopressinInvest Ophthalmol Vis Sci.(2010 Mar)
75.^Jones SB, Toews ML, Turner JT, Bylund DBAlpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP productionProc Natl Acad Sci U S A.(1987 Mar)
76.^Jones SB, Bylund DBCharacterization and possible mechanisms of alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cellsJ Biol Chem.(1988 Oct 5)
78.^Krall JF, Jamgotchian NForskolin refractoriness. Exposure to the diterpene alters guanine nucleotide-dependent adenylate cyclase and calcium-uptake activity of cells cultured from the rat aortaBiochem J.(1987 Jan 15)
79.^Barovsky K, Pedone C, Brooker GForskolin-stimulated cyclic AMP accumulation mediates protein synthesis-dependent refractoriness in C6-2B rat glioma cellsJ Cyclic Nucleotide Protein Phosphor Res.(1983)